Valerie Jarrett, Senior Advisor to the Obama Foundation, talks to Andrew Ross Sorkin and members of CNBC’s Workforce Executive Council about how recent events, including the Black Lives Matter protests, are changing the way we work and how organizations and their leaders can move forward in response.
As drugmakers race to develop Covid-19 vaccines and therapies, Dr. Luciana Borio, former Director for Medical and Biodefense Preparedness at the National Security Council, talks to CNBC’s Meg Tirrell about the technology behind the vaccines, our ability to scale production, and the public’s willingness to get a vaccinated.
Iceland has been successful in containing coronavirus without resorting to draconian measures. Dr. Kari Stefansson, Founder and CEO of deCODE genetics in Reykjavik, details how his lab partnered with the Icelandic government to effectively test and track the virus, and how the U.S. can do the same.
Nonprofit research group IAVI is collaborating with Merck on a coronavirus vaccine. Dr. Mark Feinberg, IAVI President & CEO, on how scientists are applying the technology from a successful Ebola vaccine to quickly develop one for Covid-19.
Bristol Myers Squibb CEO Dr. Giovanni Caforio talks to CNBC’s Jim Cramer about his company’s response to coronavirus and the pharmaceutical industry’s unprecedented level of cooperation in developing a treatment and vaccine.
As the world tests, tracks and traces, what have we learned from this pandemic? Former CDC Director Dr. Julie Gerberding and Scripps Research Institute’s Dr. Eric Topol discuss the lessons we’re taking away from our own response to coronavirus, the strategies being employed by other countries, and possible outcomes for the end of this pandemic.
If this pandemic plays out like a baseball game, former FDA Commissioner Scott Gottlieb says we’re only in the second inning. He joins CNBC’s Tyler Mathisen and Meg Tirrell to talk testing, vaccines, and what we’re still learning about the virus.
With human lives and global economies in mind, Pfizer CEO Albert Bourla has reallocated many of his company’s resources to focus on coronavirus. In conversation with CNBC’s Meg Tirrell, he discusses vaccine development, timeline, and cost
With the pharmaceutical industry laser-focused on coronavirus, the CEOs of drugmakers Moderna and Regeneron discuss the unprecedented ways their companies are working to test and produce the drugs that they hope will work against the virus.
Special Episode: Dr. Ali Khan, Dean of the University of Nebraska's College of Public Health, and a 23-year veteran of the CDC, has traveled the globe investigating infectious diseases like SARS and Ebola. As part CNBC’s “Healthy Returns: The Path Forward” series, he shares the lessons that past outbreaks can teach us about Covid-19, how other countries’ approaches to containing the disease have succeeded, and the challenges that we may still face even after a vaccine is developed.
How are the Work From Home tools and practices we’re using today changing the workplace of the future? CNBC’s Jon Fortt talks to EY CEO Carmine Di Sibio and MIT’s Elisabeth Reynolds about the pandemic’s lasting impact on how we achieve and measure productivity.
Special Episode: What is the safest and smartest way for states to reopen? Do promising drug trial results mean we’re closer to an end of this pandemic? What’s it like to be a non-COVID hospital patient right now? CNBC’s Meg Tirrell interviews Dr. Leana Wen, Public Health Professor at George Washington University and former Health Commissioner of Baltimore.
Understanding the accuracy, efficacy and outcomes of COVID-19 tests and treatments. Former FDA Commissioner Dr. Scott Gottlieb joins CNBC’s Senior Health and Science reporter Meg Tirrell for a deep dive into the various tests and treatments currently being employed and developed for COVID-19. This conversation is part of CNBC’s “Healthy Returns: The Path Forward” series.
CNBC’s Meg Tirrell interviews epidemiologist Dr. Michael Osterholm, Director of the Center for Infectious Disease Research and Policy, about the years-long road ahead in the fight against COVID-19, what’s currently working and not working to slow transmission, how and when we can start to re-open the country, and what the world will look like on the other side of this crisis. This conversation is part of CNBC’s “Healthy Returns: The Path Forward” series, focused on the COVID-19 pandemic.
Amid a crisis like the COVID-19 pandemic, how can leaders ensure that their organizations not only survive, but come out stronger on the other side? Former Cisco CEO John Chambers and best-selling author Daniel Pink open their “crisis playbooks” and share strategies for effective leadership during this critical time.
Just weeks after becoming CEO, Motorola’s Greg Brown faced a critical choice: break up the 90-year-old company, or risk bankruptcy. Speaking with CNBC’s Becky Quick, Brown shares the leadership advice that helped him make the toughest decision of his career, how he turned his biggest adversary into his mentor, and why businesses should “never let a good crisis go to waste.”
As CEO of Activision Blizzard, the company behind Candy Crush and Call of Duty , Bobby Kotick has led the video game industry’s evolution from console to mobile to e-sports. In a candid conversation with CNBC’s Becky Quick, Kotick shares colorful stories about the company’s early days and what the future of gaming looks like.
Under CEO Mark Bertolini, Aetna transformed from an insurance company to a health services company, introducing preventative care and alternative therapies to the healthcare industry. Bringing his personal experience as a patient to the job, Bertolini implemented policies at Aetna that positively impacted patient outcomes, employee performance, and the company’s bottom line.
While many brick-and-mortar retailers are losing market share to e-tailers, Walmart’s online and physical stores are thriving. In conversation with Becky Quick, Walmart CEO Doug McMillon shares his strategy for balancing online and physical store growth, betting on in-home grocery delivery, and the decision that lost $21 billion in a single day. McMillion joined Becky Quick at CNBC’s “Evolve” conference in November 2019.
Mark Thompson, New York Times CEO, on leading the company through a digital transformation, investing in content, and changing operations at the 169-year-old newspaper to meet the demands of a 24/7 news cycle.
Levi’s blue jeans have evolved from work uniforms for gold miners to fashion pieces for consumers around the world. Hear from Chip Bergh, Levi Strauss & Co. CEO, on how the iconic brand has remained relevant in retail by navigating changes in style, innovating its manufacturing process, and facing challenges from athleisure wear head-on, all while staying true to the company’s core values. Bergh spoke at CNBC’s “Evolve” Conference in Los Angeles.
Brian Niccol took over as Chipotle CEO in early 2018, just as the company was struggling with food safety concerns, store closures, and a falling stock price. In less than 2 years, he turned the company around by implementing delivery service, a loyalty program, and a focus on digital ordering. At CNBC’s “Evolve” conference, Niccol spoke candidly about his leadership strategy, what he looks for in a new employee, and the two most powerful words in business.
Introducing The Keynote by CNBC Events. Get a front row seat at CNBC’s events and hear directly from the visionary executives, innovators, leaders and influencers taking the stage at CNBC’s live events series, including Evolve, @Work, and more. Hear the best sound from the fireside chats, keynote talks, and panels, with added, behind-the-scenes commentary from the moderators and interviewers who were on stage at the event, and other CNBC beat reporters close to the action. Coming soon.
